Found 2 results
Filters: Author is M. Yildiz  [Clear All Filters]
M. Yildiz, Karkucak, M., Yakut, T., Gorukmez, O., and Ozmen, A., Lack of association of genetic polymorphisms of angiotensin-converting enzyme gene I/D and glutathione-S-transferase enzyme T1 and M1 with retinopathy of prematures, vol. 9, pp. 2131-2139, 2010.
Abbas A, Delvinquiere K, Lechevrel M, Lebailly P, et al. (2004). GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J. Gastroenterol. 10: 3389-3393. PMid:15526353   Balogh A, Derzbach L, Vannay A and Vásárhelyi B (2006). Lack of association between insulin-like growth factor I receptor G (+3174)A polymorphism and retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 244: 1035-1038. PMid:16362313   Bányász I, Bokodi G, Vannay A, Szebeni B, et al. (2006). Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. Curr. Eye Res. 31: 685-690. PMid:16877277   Barceló A, Elorza MA, Barbé F, Santos C, et al. (2001). Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur. Respir. J. 17: 728-732. PMid:11401071   Beneteau-Burnat B and Baudin B (1991). Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. Crit. Rev. Clin. Lab. Sci. 28: 337-356. PMid:1663362   Bossi E and Koerner F (1995). Retinopathy of prematurity. Intensive Care Med. 21: 241-246. PMid:7790613   Habdous M, Siest G, Herbeth B, Vincent-Viry M, et al. (2004). Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies. Ann. Biol. Clin. 62: 15-24.   Haider MZ, Devarajan LV, Al-Essa M, Srivastva BS, et al. (2000). Missense mutations in norrie disease gene are not associated with advanced stages of retinopathy of prematurity in Kuwaiti arabs. Biol. Neonate 77: 88-91. PMid:10657684   Haider MZ, Devarajan LV, Al-Essa M, Srivastva BS, et al. (2001). Retinopathy of prematurity: mutations in the Norrie disease gene and the risk of progression to advanced stages. Pediatr. Int. 43: 120-123. PMid:11285060   Haider MZ, Devarajan LV, Al-Essa M and Kumar H (2002). Angiotensin-converting enzyme gene insertion/deletion polymorphism in Kuwaiti children with retinopathy of prematurity. Biol. Neonate 82: 84-88. PMid:12169829   Hayes JD, Flanagan JU and Jowsey IR (2005). Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45: 51-88. PMid:15822171   Hayes LW, Goguen CA, Ching SF and Slakey LL (1978). Angiotensin-converting enzyme: accumulation in medium from cultured endothelial cells. Biochem. Biophys. Res. Commun. 82: 1147-1153.   Hutcheson KA, Paluru PC, Bernstein SL, Koh J, et al. (2005). Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol. Vis. 11: 501-508. PMid:16052165   Karna P, Muttineni J, Angell L and Karmaus W (2005). Retinopathy of prematurity and risk factors: a prospective cohort study. BMC Pediatr. 5: 18. PMid:15985170 PMCid:1175091   Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, et al. (2008). The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 246: 1467-1475. PMid:18546007   Lee YJ and Tsai JC (2002). ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25: 1002-1008. PMid:12032106   Ng YK, Fielder AR, Shaw DE and Levene MI (1988). Epidemiology of retinopathy of prematurity. Lancet 2: 1235-1238.   Nishimura H, Tsuji H, Masuda H, Kasahara T, et al. (1999). The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thromb. Haemost. 82: 1516-1521. PMid:10595647   Onaran I, Ozaydin A, Ozdas SB and Ulutin T (2000a). Inhibition of platelet function by GSTM1-null human peripheral lymphocytes exposed to benzo(a)pyrene-induced challenge. Cell Biol. Toxicol. 16: 313-323. PMid:11201055   Onaran I, Ozaydin A, Akbas F, Gultepe M, et al. (2000b). Are individuals with glutathione S-transferase GSTT1 null genotype more susceptible to in vitro oxidative damage? J. Toxicol. Environ. Health A 59: 15-26. PMid:10681096   Rusai K, Vannay A, Szebeni B, Borgulya G, et al. (2008). Endothelial nitric oxide synthase gene T-786C and 27-bp repeat gene polymorphisms in retinopathy of prematurity. Mol. Vis. 14: 286-290. PMid:18334945 PMCid:2263012   Shah VA, Yeo CL, Ling YL and Ho LY (2005). Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann. Acad. Med. Singapore 34: 169-178. PMid:15827664   Shastry BS (2007). Assessment of the contribution of insulin-like growth factor I receptor 3174 G→A polymorphism to the progression of advanced retinopathy of prematurity. Eur. J. Ophthalmol. 17: 950-953. PMid:18050122   Shastry BS (2009). Lack of association of VEGF (-2578 C→A) and ANG 2 (-35 G→C) gene polymorphisms with the progression of retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 247: 859-860. PMid:19018553   Shastry BS and Qu X (2007). Lack of association of the VEGF gene promoter (-634 G→C and -460 C→T) polymorphism and the risk of advanced retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 245: 741-743. PMid:17119993   Shastry BS, Pendergast SD, Hartzer MK, Liu X, et al. (1997). Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch. Ophthalmol. 115: 651-655. PMid:9152134   Smith LE (2002). Pathogenesis of retinopathy of prematurity. Acta Paediatr. 91: 26-28.   Strange RC, Spiteri MA, Ramachandran S and Fryer AA (2001). Glutathione-S-transferase family of enzymes. Mutat. Res. 482: 21-26.   Subhani M, Combs A, Weber P, Gerontis C, et al. (2001). Screening guidelines for retinopathy of prematurity: the need for revision in extremely low birth weight infants. Pediatrics 107: 656-659. PMid:11335739   Uzunoğlu S, Acar H, Okudan N, Gökbel H, et al. (2006). Evaluation of the association between null genotypes of glutathione-S-transferases and Behcet's disease. Arch. Dermatol. Res. 297: 289-293. PMid:16283344   Van der Hel OL, Peeters PH, Hein DW, Doll MA, et al. (2003). NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics 13: 399-407. PMid:12835615   Vaughan DE (1997). The renin-angiotensin system and fibrinolysis. Am. J. Cardiol. 79: 12-16.   Yaggi HK, Concato J, Kernan WN, Lichtman JH, et al. (2005). Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 353: 2034-2041. PMid:16282178   Zhong SL, Zhou SF, Chen X, Chan SY, et al. (2006). Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. Eur. J. Pharm. Sci. 28: 77-85. PMid:16488119